Nitric Oxide (NO) is an important cellular signaling molecule involved in many physiological and pathological processes. Building from Nobel Prize-winning Nitric Oxide research studies, Dr. Nathan Bryan developed a breakthrough, NO-producing formulation.

From this foundation, AusTech has developed a platform of solutions tailored for pharmaceutical markets. By modifying the compound formulation, both efficacy and delivery may be targeted to specific indications for achievement of therapeutic benefit.

Proven through numerous clinical studies, the AusTech team is now poised to deliver key innovations to the healthcare industry, providing relief to those suffering from indications related to NO deficiencies. Below are specific indications for which the restoration of NO levels could potentially lead to improvement over existing therapeutics:

For further information on how our technology can be applied for these, and many other indications, please contact us.